It’s either going to be a blessing or a curse that our first biggest true test is the most difficult.
It is the test that all our other indications will be judged and assigned promise, probability, value, etc.
We’ve been throwing powerful words around for years: homeostasis, prophylactic, reverse, less dementia, upstream, gene pathways, etc…
Will all these words will be just words or will they carry weight? If our trial isn’t that great, we go back to trying to prove these words have meaning for our “platform”.
All those potential indications floating around the brain will be that much further out of reach in the minds of investors.
Moment of truth is here. Exciting and scary. For me at least.